MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
29.31
-0.47 (-1.58%)
At close: May 29, 2026, 4:00 PM EDT
29.38
+0.07 (0.24%)
After-hours: May 29, 2026, 6:50 PM EDT
MapLight Therapeutics Employees
MapLight Therapeutics had 133 employees as of December 31, 2025. The number of employees increased by 70 or 111.11% compared to the previous year.
Employees
133
Change
70
Growth
111.11%
Revenue / Employee
n/a
Profits / Employee
-$1,499,850
Market Cap
1.33B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 133 | 30 | 29.13% |
| Sep 30, 2025 | 114 | - | - |
| Jun 30, 2025 | 109 | 35 | 47.30% |
| Mar 31, 2025 | 103 | 29 | 39.19% |
| Mar 31, 2024 | 74 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Immunocore Holdings | 524 |
| UroGen Pharma | 298 |
| KalVista Pharmaceuticals | 275 |
| Maze Therapeutics | 141 |
| MoonLake Immunotherapeutics | 130 |
| Septerna | 130 |
| Bicara Therapeutics | 103 |
MPLT News
- 3 days ago - MapLight Therapeutics initiated with a Buy at UBS - TheFly
- 8 days ago - Craig-Hallum bullish on MapLight Therapeutics, initiates with a Buy - TheFly
- 8 days ago - MapLight Therapeutics initiated with a Buy at Craig-Hallum - TheFly
- 15 days ago - MapLight Therapeutics reports Q1 EPS ($1.34), consensus ($1.12) - TheFly
- 15 days ago - MapLight Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 15 days ago - MapLight Therapeutics Earnings release: Q1 2026 - Filings
- 15 days ago - MapLight Therapeutics Quarterly report: Q1 2026 - Filings
- 15 days ago - MapLight Therapeutics initiated with an Outperform at LifeSci Capital - TheFly